Hematopoietic stem cells attract wide interest in biomedical research and basic science alike. They are used in transplantation experiments involving cancer patients and are popular targets for introducing genes in protocols aimed at gene therapy. Blood cell differentiation is one of the major paradigms for understanding the molecular processes involved in tissue diversification. In spite of a wealth of information about multipotent progenitors and the different cell types they generate, little is known about what happens in between. Here we propose to study the intermediates and pathways taken during differentiation using a novel in vivo labeling approach that allows us to analyze cells from various lineages without the need for staining procedures. This will be achieved by creating mice in which myeloid, megakaryocytic, erythroid and eosinophilic cell populations are labeled with various forms of fluorescent proteins, using homologous recombination and transgenic approaches. These mouse lines will be crossed to generate bi- or tri-colored lines and their bone marrow analyzed, using a combination of fluorescence microscopy, FACS and in vitro colony assays. To directly visualize the formation of differentiated cells, multipotent progenitors from the various mouse lines will be seeded in culture and recorded by time-lapse fluorescence microscopy using different filters. Using similar approaches we will also determine whether the transcription factor GATA-1 is capable of reprogramming hematopoietic cells in vivo.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Mufson, R Allan
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albert Einstein College of Medicine
Anatomy/Cell Biology
Schools of Medicine
United States
Zip Code
Ye, Min; Graf, Thomas (2007) Early decisions in lymphoid development. Curr Opin Immunol 19:123-8
Laiosa, Catherine V; Stadtfeld, Matthias; Graf, Thomas (2006) Determinants of lymphoid-myeloid lineage diversification. Annu Rev Immunol 24:705-38
Laiosa, Catherine V; Stadtfeld, Matthias; Xie, Huafeng et al. (2006) Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors. Immunity 25:731-44
Stadtfeld, Matthias; Varas, Florencio; Graf, Thomas (2005) Fluorescent protein-cell labeling and its application in time-lapse analysis of hematopoietic differentiation. Methods Mol Med 105:395-412
Ye, Min; Ermakova, Olga; Graf, Thomas (2005) PU.1 is not strictly required for B cell development and its absence induces a B-2 to B-1 cell switch. J Exp Med 202:1411-22
Xie, Huafeng; Ye, Min; Feng, Ru et al. (2004) Stepwise reprogramming of B cells into macrophages. Cell 117:663-76
Heck, Susanne; Ermakova, Olga; Iwasaki, Hiromi et al. (2003) Distinguishable live erythroid and myeloid cells in beta-globin ECFP x lysozyme EGFP mice. Blood 101:903-6
Ganz, Tomas; Gabayan, Victoria; Liao, Hsiang-I et al. (2003) Increased inflammation in lysozyme M-deficient mice in response to Micrococcus luteus and its peptidoglycan. Blood 101:2388-92
Ye, Min; Iwasaki, Hiromi; Laiosa, Catherine V et al. (2003) Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential. Immunity 19:689-99
Graf, Thomas (2002) Differentiation plasticity of hematopoietic cells. Blood 99:3089-101